dGH™ provides true de novo unbiased detection
ABSTRACT Structural variants, such as inversions and translocations, are common by-products of CAR T-cell engineering processes such as CRISPR-Cas9 editing. These variants are formed [...]
ABSTRACT Structural variants, such as inversions and translocations, are common by-products of CAR T-cell engineering processes such as CRISPR-Cas9 editing. These variants are formed [...]
Longmont, CO March 27, 2023 – KromaTiD, a single-cell analysis life science tools company focused on the research, development, and commercialization of technology solutions for [...]
The original KromaTiD assay, dGH SCREEN™ was initially utilized by NASA to monitor the effects of ionizing deep space radiation in their astronauts. Famously dubbed [...]
iPSC’s (induced Pluripotent Stem Cells) are an important cell for cancer studies. Human embryonic stem cells have two important properties; self-renewal (pluripotent) and an ability to [...]
Microscopic study of the cells in our bodies is what Cytotechnology is all about. Taking our cells, putting them on a slide and reading them [...]
As technologies evolve, therapies for cancer have advanced and more and more researchers are finding out how the science of our bodies make us ill [...]
Cytogenetics has been a key part of biology since 1842, a Swiss botanist named Karl Nägeli had first discovered chromosomes in pollen. Many decades later [...]
Last month March 2022, the FDA released Draft guidelines for Human Gene Therapy Products Incorporating Human Genome Editing. This guideline is a Draft and as [...]
DNA probes are simply oligonucleotides (short sequences of DNA) approximately 100-1000bp long, that are used to detect the presence of [...]
Mutations in the TP53 Gene are where the most frequent alterations in human cancers show. These alterations cause Li-Fraumeni syndrome, creating [...]